Keros Therapeutics, Inc. - Common Stock (KROS)
CUSIP: 492327101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 30,507,667
- Total 13F shares
- 16,029,747
- Share change
- +4,248,980
- Total reported value
- $1,129,296,879
- Price per share
- $70.54
- Number of holders
- 81
- Value change
- +$301,336,670
- Number of buys
- 69
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 492327101?
CUSIP 492327101 identifies KROS - Keros Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 492327101:
Institutional Holders of Keros Therapeutics, Inc. - Common Stock (KROS) as of Q4 2020
As of 31 Dec 2020,
Keros Therapeutics, Inc. - Common Stock (KROS) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,029,747 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Foresite Capital Management IV, LLC, BlackRock Inc., VR Adviser, LLC, VANGUARD GROUP INC, Consonance Capital Management LP, Nantahala Capital Management, LLC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
49
Q4 2020 holders
81
Holder diff
32
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.